Wnt-14b I is a member of the Wnt family of proteins that play a crucial role in the regulation of developmental processes. These proteins are secreted lipid-modified signaling glycoproteins that bind to receptor complexes on the cell surface. The Wnt-14b I protein is involved in the complex signaling networks that govern cell fate decisions, tissue patterning, and the maintenance of cell types within various tissues. Wnt proteins, including Wnt-14b I, are fundamental to the intricate choreography of cellular communication, influencing the expression of target genes that drive embryonic development and contribute to the dynamic homeostasis of adult tissues.
Several compounds can modulate the expression of Wnt-14b I, albeit through indirect mechanisms rather than direct interaction with the protein. Retinoic acid, for example, may enhance Wnt-14b I expression by engaging transcriptional mechanisms that govern developmental gene expression patterns. Likewise, Lithium chloride has been shown to affect intracellular signaling pathways, which may result in the upregulation of Wnt-14b I. Cholecalciferol, or Vitamin D3, upon conversion to its active form, can also influence the expression of Wnt-14b I by engaging with its nuclear receptor, which may coactivate certain signaling pathways linked to the Wnt family. Forskolin, which elevates intracellular cAMP levels, could potentially upregulate Wnt-14b I by activating downstream components that influence gene expression. Similarly, compounds like Galunisertib, which targets specific signaling receptors, and Wnt-C59, an inhibitor of an enzyme critical for Wnt protein maturation, may also affect the cellular mechanisms that control the levels of Wnt-14b I expression. These various compounds, each interacting with distinct molecular pathways, underscore the complex regulatory network that shapes Wnt-14b I activity within the biological system.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid may orchestrate a transcriptional response that enhances the expression of Wnt-14b, influencing cellular differentiation and embryonic development. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride may lead to the accumulation of intracellular signaling molecules, which in turn could selectively elevate Wnt-14b transcription within the signaling pathway. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
The biologically active form of Cholecalciferol could interact with its receptors, coactivating signaling and potentially leading to a targeted increase in Wnt-14b expression during cellular differentiation and growth. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is known to raise intracellular cAMP levels, which might activate downstream targets and culminate in the targeted transcriptional upregulation of Wnt-14b. | ||||||
LY2157299 | 700874-72-2 | sc-391123 sc-391123A | 5 mg 10 mg | $213.00 $359.00 | 3 | |
As an inhibitor of a specific signaling receptor, LY2157299 may relieve repression of signaling pathways, potentially resulting in a compensatory expression enhancement of Wnt-14b. | ||||||
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $214.00 $326.00 $1275.00 | 1 | |
Wnt-C59 inhibits a specific enzyme, potentially leading to an adaptive cellular response that enhances the expression of Wnt-14b. | ||||||
IWR-1-endo | 1127442-82-3 | sc-295215 sc-295215A | 5 mg 10 mg | $82.00 $135.00 | 19 | |
IWR-1-endo, by interfering with a specific signaling complex, could inadvertently lead to an increase in signaling activity, promoting the transcriptional activation of Wnt-14b. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone may upregulate Wnt-14b through receptor activation, which binds to specific response elements adjacent to the Wnt-14b gene, influencing its transcription. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
GSK-3 Inhibitor XVI, by inhibiting a specific kinase, may cause an increase in signaling activity, which is a pivotal factor in the subsequent transcriptional upregulation of Wnt-14b. | ||||||